Overview

• Kosolcharoen created Liveyon LLC and Genetech Inc. to market stem cell products from umbilical cord blood.
• The products were falsely advertised as treatments for serious conditions like Alzheimer's and heart disease.
• FDA and CDC reports linked these products to bacterial infections in multiple states.
• Kosolcharoen directed false labeling of products as 'for research purposes only' to evade FDA scrutiny.
• Sentencing is scheduled for September 23, with a maximum possible sentence of three years in federal prison.